We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hikma Pharmaceuticals Plc | LSE:HIK | London | Ordinary Share | GB00B0LCW083 | ORD SHS 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
38.00 | 2.02% | 1,918.50 | 1,925.00 | 1,927.00 | 1,937.50 | 1,887.50 | 1,903.00 | 504,022 | 16:35:27 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 2.88B | 190M | 0.8594 | 22.41 | 4.26B |
TIDMHIK
RNS Number : 5563Y
Hikma Pharmaceuticals Plc
22 August 2018
Notification and public disclosure of transactions by persons discharging managerial responsibilities
1 Details of the person discharging managerial responsibilities / person closely associated a) Name Bassam Kanaan 2 Reason for the notification a) Position/status Chief Strategy and Corporate Development Officer b) Initial notification Initial notification /Amendment 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor a) Name Hikma Pharmaceuticals PLC b) LEI 549300BNS685UXH4JI75 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted a) Description of Description: Ordinary shares of 10 pence each the financial ID Code: GB00B0LCW083 instrument, type of instrument and identification code b) Nature of the Disposal of 30,000 Ordinary Shares of 10 pence transaction each in Hikma Pharmaceuticals PLC. c) Price(s) and Price(s): GBP19.17 volume(s) Volume(s): 30,000 d) Aggregated information Aggregated volume: 30,000 Price: GBP575,100 e) Date of the transaction 20 to 21 August 2018 f) Place of the London Stock Exchange (XLON) transaction
Peter Speirs, Company Secretary, Responsible for releasing this announcement
22 August 2018
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHGIGDICXDBGID
(END) Dow Jones Newswires
August 22, 2018 04:41 ET (08:41 GMT)
1 Year Hikma Pharmaceuticals Chart |
1 Month Hikma Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions